Federal Register / Vol. 79, No. 218 / Wednesday, November 12, 2014 / Notices 67177 

organizations may directly benefit from 

the findings of this study. 

Blood donors are tested for 

transfusion-transmissible infections 

including HIV when they present to 

donate, and test result information as 

well as demographic data will be 

routinely collected in a database at the 

five blood centers participating in 

REDS–III studies (located in the cities of 

Chongqing, Liuzhou, Luoyang, 

Mianyang, and Urumqi). These data will 

allow for calculation of HIV incidence, 

prevalence, and residual risk. 

Additionally, a case-control study will 

be conducted over a 2 and 1/2 year 

period to evaluate the risk factors 

associated with HIV infection among 

blood donors. Cases will be defined as 

potential donors who deny risks on the 

donor screening questionnaire but are 

found to be positive on HIV testing 

(their donation is discarded), HIVpositive donors who gave blood at one 

of the five blood centers as stated above 

(primary sites)or at blood centers 

located in the Guangxi Autonomous 

Region (peripheral sites, recruited 

through the Guangxi CDC for this study 

only but not other REDS–III studies) 

will be eligible to participate and 

complete a Risk Factor Questionnaire 

that will assess general demographic 

and risk factor information pertinent to 

HIV infection. Controls will be negative 

for HIV on confirmatory testing. 

Assuming 50% response rate, it is 

anticipated that 390 HIV-positive 

donors and 960 controls will participate 

in the case control study. The results of 

this study will contribute to global HIV 

surveillance and prevention, provide a 

broader global understanding of HIV 

epidemiology, and support public 

health efforts to most effectively manage 

and potentially prevent HIV 

transmission both worldwide and in the 

US. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated burden hours are 450. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

HIV Risk factor Q .............................. Blood donors—Case Primary Sites 210 1 20/60 70 

Blood donors—Case peripheral 

sites.

180 1 20/60 60 

Blood donors—Control primary sites 540 1 20/60 180 

Blood donors—Control peripheral 

sites.

420 1 20/60 140 

Dated: October 28, 2014. 

Lynn Susulske, 

NHLBI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2014–26761 Filed 11–10–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

The National Institute of Mental Health 

(NIMH) Draft Strategic Plan; Request 

for Comments 

SUMMARY: NIMH is revising its 2008 

Strategic Plan to guide the Institute’s 

research efforts and priorities over the 

next five years (2015–2020). The 

purpose of this Notice is to seek input 

from the public about the draft NIMH 

2015 Strategic Plan. The draft plan will 

be publicly available through the NIMH 

Draft Strategic Plan Web page (http://

www.nimh.nih.gov/about/strategicplanning-reports/review-the-draft-2015- 

nimh-strategic-plan.shtml) for a 30-day 

period beginning on the publication 

date of this Notice. The public is invited 

to provide comments via the email 

address or postal address provided in 

this Notice and on the NIMH Draft 

Strategic Plan Web page. 

DATES: To ensure consideration, your 

responses must be received within a 30- 

day period that begins on the 

publication date of this Notice. 

ADDRESSES: Responses to this Notice 

should be submitted electronically 

using email to nimhstratplan@

mail.nih.gov. Alternatively, written 

responses can be submitted by mail to 

the Science Writing, Press, and 

Dissemination Branch, 6001 Executive 

Boulevard, Room 6200, MSC 9663. 

Bethesda, MD 20892–9663. 

FOR FURTHER INFORMATION CONTACT: 

Please contact our NIMH Information 

Specialists using the following contact 

information: telephone: 1–866–615– 

6464 (toll-free), 1–301–443–8431 (TTY), 

1–866–415–8051 (TTY toll-free). Fax: 1– 

301–443–4279, Email: nimhinfo@

nih.gov 

SUPPLEMENTARY INFORMATION: 

Background 

The National Institute of Mental 

Health (NIMH) is the lead federal 

agency for research on mental illnesses. 

The mission of the NIMH is to transform 

the understanding and treatment of 

mental illnesses through basic and 

clinical research, paving the way for 

prevention, recovery, and cure. To 

fulfill its mission, the NIMH supports 

and conducts research on mental 

illnesses and the underlying basic 

science of brain and behavior; supports 

the training of scientists to carry out 

basic and clinical mental health 

research; and, communicates with 

scientists, patients, providers, and the 

general public about the science of 

mental illnesses. 

In 2008, the NIMH published a 

Strategic Plan to accelerate progress in 

basic, translational, and clinical science. 

The need to update the plan became 

clear with the increasing number of 

remarkable scientific advancements and 

the changing landscape of mental health 

care over the past six years. With the 

goals of helping individuals living with 

mental illnesses and promoting both 

prevention and cure, NIMH has revised 

its original four high-level Strategic 

Objectives as follows: (1) Define the 

biological basis of complex behaviors; 

(2) chart mental illness trajectories to 

determine when, where, and how to 

intervene; (3) develop better preventive 

and therapeutic interventions; and, (4) 

strengthen the public health impact of 

NIMH-supported research. These four 

Strategic Objectives form a broad 

roadmap for the Institute’s priorities 

over the next five years, which begins 

with the fundamental science of the 

brain and behavior, and ends with 

public health impact. Full 

implementation of these Strategies 

Objectives, will, we hope, transform the 


TKELLEY on DSK3SPTVN1PROD with NOTICES
67178 Federal Register / Vol. 79, No. 218 / Wednesday, November 12, 2014 / Notices 

diagnosis, treatment, and prevention of 

these devastating illnesses. 

Request for Comments 

This notice invites public comment 

and input on the development of the 

NIMH 2015 Strategic Plan. When 

developing your comments, we ask that 

you consider the draft plan in the 

context of the current scientific 

landscape, as well as within the context 

of broader federal, for-profit, and notfor-profit stakeholder perspectives. We 

are particularly interested in receiving 

your ideas for scientific advancements, 

new technical capabilities or tools, or 

major challenge topics that promise 

substantial change to mental health 

research if pursued. 

General Information 

Responses to this Notice are optional 

and voluntary. Any personal identifiers 

will be removed when responses are 

compiled. Proprietary, classified, 

confidential, or sensitive information 

should not be included in your 

response. This Notice is for planning 

purposes only and is not a solicitation 

for applications or an obligation on the 

part of the United States (U.S.) 

government to provide support for any 

ideas identified in response to it. Please 

note that the U.S. government will not 

pay for the preparation of any comment 

submitted or for its use of that comment. 

Privacy Act Notification Statement: 

We are requesting your comments for 

the 2015–2020 National Institute of 

Mental Health (NIMH) Strategic Plan. 

The information you provide may be 

disclosed to NIMH staff serving to 

develop the strategic plan and to 

contractors working on NIMH’s behalf. 

Submission of this information is 

voluntary. 

Collection of this information is 

authorized under 42 U.S.C. 203, 24 l, 

2891–1 and 44 U.S.C. 310 I and Section 

30 l and 493 of the Public Health 

Service Act regarding the establishment 

of the National Institutes of Health, its 

general authority to conduct and fund 

research and to provide training 

assistance, and its general authority to 

maintain records in connection with 

these and its other functions. 

Dated: November 3, 2014. 

Thomas R. Insel, 

Director, National Institute of Mental Health, 

National Institutes of Health. 

[FR Doc. 2014–26760 Filed 11–10–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; CVRS 

Member Conflicts and Continuous 

Submissions. 

Date: December 9, 2014. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Olga A. Tjurmina, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

MSC 7814, Bethesda, MD 20892, (301) 451– 

1375, ot3d@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Biological Chemistry and 

Macromolecular Biophysics. 

Date: December 10–11, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Nitsa Rosenzweig, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7760, Bethesda, MD 20892, (301) 404– 

7419, rosenzweign@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: AIDS and AIDS Related Research. 

Date: December 10, 2014. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Jose H. Guerrier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1137, guerriej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 12– 

251: Behavioral Science Track Award for 

Rapid Transition (B/START). 

Date: December 10, 2014. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Jose H. Guerrier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1137, guerriej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Radiation Therapeutics and Biology. 

Date: December 11, 2014. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Lawrence Ka-Yun Ng, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1719, ngkl@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 5, 2014. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–26671 Filed 11–10–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


TKELLEY on DSK3SPTVN1PROD with NOTICES